Molecule intelOpportunity: Lower0Crowded market

Cefadroxil

146 brands · 114 companies · product forms

Opportunity snapshot

Launch attractiveness
24
Market saturation
99
Price room
100
Regulatory risk
0
146
brands
114
companies
Rs 347.7
median price
48
price points
19.69x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 2%

Price room

Across observed sources and strengths
CheapestRs 98.62
MedianRs 347.7
Most expensiveRs 1,941.5
Spread19.69×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 19.69x across 48 trusted points (Rs 98.62-1941.5). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Cefadroxil — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(1) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

114 canonical companies and 146 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 19.69x across 48 trusted points (Rs 98.62-1941.5). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.